These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Time-dependent effects of inhaled corticosteroids on lung function, bronchial hyperresponsiveness, and airway inflammation in asthma. Mehta V; Stokes JR; Berro A; Romero FA; Casale TB Ann Allergy Asthma Immunol; 2009 Jul; 103(1):31-7. PubMed ID: 19663124 [TBL] [Abstract][Full Text] [Related]
6. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. Smith AD; Cowan JO; Brassett KP; Herbison GP; Taylor DR N Engl J Med; 2005 May; 352(21):2163-73. PubMed ID: 15914548 [TBL] [Abstract][Full Text] [Related]
7. Predictors for failed dose reduction of inhaled corticosteroids in childhood asthma. Li AM; Tsang TW; Lam HS; Sung RY; Chang AB Respirology; 2008 May; 13(3):400-7. PubMed ID: 18399863 [TBL] [Abstract][Full Text] [Related]
8. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial. Rowe BH; Wong E; Blitz S; Diner B; Mackey D; Ross S; Senthilselvan A Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245 [TBL] [Abstract][Full Text] [Related]
9. Acinar effect of inhaled steroids evidenced by exhaled nitric oxide. Van Muylem A; Kerckx Y; Michils A J Allergy Clin Immunol; 2010 Oct; 126(4):730-735.e2. PubMed ID: 20709384 [TBL] [Abstract][Full Text] [Related]
10. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Fritscher LG; Rodrigues MT; Zamel N; Chapman KR Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684 [TBL] [Abstract][Full Text] [Related]
11. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715 [TBL] [Abstract][Full Text] [Related]
12. Effect of inhaled steroid therapy on exhaled nitric oxide and bronchial responsiveness in children with asthma. Nishio K; Odajima H; Motomura C; Nakao F; Nishima S J Asthma; 2006 Dec; 43(10):739-43. PubMed ID: 17169825 [TBL] [Abstract][Full Text] [Related]
13. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma. Schuh S; Dick PT; Stephens D; Hartley M; Khaikin S; Rodrigues L; Coates AL Pediatrics; 2006 Aug; 118(2):644-50. PubMed ID: 16882819 [TBL] [Abstract][Full Text] [Related]
14. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial). Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768 [TBL] [Abstract][Full Text] [Related]
15. [Exhaled nitric oxide (NO) in asthma patients with acute exacerbation]. Zietkowski Z; Bodzenta-Łukaszyk A Pol Merkur Lekarski; 2004 Feb; 16(92):111-4. PubMed ID: 15176291 [TBL] [Abstract][Full Text] [Related]
16. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Dijkstra A; Vonk JM; Jongepier H; Koppelman GH; Schouten JP; ten Hacken NH; Timens W; Postma DS Thorax; 2006 Feb; 61(2):105-10. PubMed ID: 16308336 [TBL] [Abstract][Full Text] [Related]
17. Effects of steroid therapy on inflammatory cell subtypes in asthma. Cowan DC; Cowan JO; Palmay R; Williamson A; Taylor DR Thorax; 2010 May; 65(5):384-90. PubMed ID: 19996343 [TBL] [Abstract][Full Text] [Related]
18. Association of exhaled nitric oxide to asthma burden in asthmatics on inhaled corticosteroids. Zeiger RS; Schatz M; Zhang F; Crawford WW; Kaplan MS; Roth RM; Chen W J Asthma; 2011 Feb; 48(1):8-17. PubMed ID: 21155706 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study. Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960 [TBL] [Abstract][Full Text] [Related]
20. Effect of fluticasone on markers of inflammation and quality of life in steroid-naive patients with mild asthma. Ehrs PO; Sundblad BM; Larsson K Clin Respir J; 2010 Jan; 4(1):51-8. PubMed ID: 20298418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]